Edwards Lifesciences Corporation · NYSE:EW

Lippis Daniel J. sold 620 Edwards Lifesciences Corporation shares (Form 4)

Traded May 18, 2026 · Filed May 18, 2026

On May 18, 2026, Lippis Daniel J. (CVP, TAVR) sold 620 Edwards Lifesciences Corporation shares at US$81.14 for US$50,307 under a trading plan, leaving 40,411 shares. Filed May 18, 2026 (Form 4).

Sold
620 shares
Price
US$81.14
Value
US$50,307
Holding after
40,411 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CVP, TAVR

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockOption exercise620US$72.6841,031Direct
May 18, 2026Common StockSale620US$81.1440,411Direct

Source

View original at SEC

Related